Teleflex said it plans to sell three of its businesses for a total of $2.03 billion in cash as it continues to focus on its core markets.

Teleflex is splitting its business into two independently traded entities, with a completion date set for mid-2026. The company’s urology, acute care, and OEM businesses will be grouped under Teleflex ...

Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.” ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

Medical device maker Teleflex said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and hospital businesses. Shares of the company were ...

CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...

One of Minnesota’s largest publicly traded medtech firms, Vascular Solutions, revealed on Friday that Teleflex Inc. will purchase the company and all of its assets for $1 billion. Howard Root, who ...

New, independent, publicly traded company (NewCo) consisting of Teleflex’s Urology, Acute Care, and OEM businesses. RemainCo will consist of Teleflex’s Vascular Access, Interventional, and Surgical ...

The stock price of Teleflex, best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down over 4% ...